Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
Open accessThe DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Abstract
Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniques, such as stereotactic radiofrequency lesions. While serendipity has played a role in developing DBS as a therapy, research during the past two decades has shown that electrical neuromodulation is far more than a functional lesion that can be switched on and off. This understanding broadens the field to enable new types of stimulation, clinical indications, and research. This review highlights the complex effects of DBS from the single cell to the neuronal network. Specifically, we examine the electrical, cellular, molecular, and neurochemical mechanisms of DBS as applied to Parkinson's disease and other emerging applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed · doi:10.18154/rwth-conv-084442 · Cited by 3,639
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
Which elements are excited in electrical stimulation of mammalian central nervous system: A review
Ranck, J. B. (1975) · Brain Research · doi:10.1016/0006-8993(75)90364-9 · Cited by 2,024 · cited 6×
“…(ii) the type of ion channels on the cell membrane of a soma or axon (Hoang et al, 2017); (iii) the diameter and degree of myelination of axons (Ranck, 1975; Nowak & Bullier, 1998; Gubellini et al, 2009; Carron et al, 2013); (iv) the orientation of axons in relation to the electrode (Ranck,…”
BackgroundInfluentialElectrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy
Fisher, R., Salanova, V., Witt, T., Worth, R., Henry, T., Gross, R., Oommen, K., Osorio, I., Nazzaro, J., Labar, D., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02536.x · Cited by 1,918 · cited 2×
“Other clinical indications are treatment-resistant epilepsy (Fisher et al, 2010) and obsessive–compulsive disorder (OCD; Greenberg et al, 2006).”
BackgroundResultDalgleish, T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1432 · Cited by 1,849
Optical Deconstruction of Parkinsonian Neural Circuitry
Gradinaru, V., Mogri, M., Thompson, K. R., Henderson, J. M., & Deisseroth, K. (2009) · Science · doi:10.1126/science.1167093 · Cited by 1,526 · cited 1×
“…STN axons but also afferent fibers projecting to STN dendrites and cell bodies, inhibitory (GABAergic) and excitatory (glutamatergic) afferent fibers can be activated and act on the STN cell body itself (Dostrovsky et al, 2000; Anderson et al, 2004; Gradinaru et al, 2009; Chiken & Nambu, 2013).”
BackgroundNeurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430 · cited 2×
“DBS is an established treatment for movement disorders such as Parkinson’s disease (PD; Brown et al, 1999; Schuepbach et al, 2013), several forms of tremor (Hubble et al, 1996), and dystonia (Kumar et al, 1999).”
BackgroundWang, E.-S., Yao, H.-B., Chen, Y.-H., Wang, G., Gao, W.-W., Sun, Y.-R., Guo, J.-G., Hu, J.-W., Jiang, C.-C., & Hu, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350082 · Cited by 1,176
Benabid, A. L., Pollak, P., Gao, D., Hoffmann, D., Limousin, P., Gay, E., Payen, I., & Benazzouz, A. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.2.0203 · Cited by 1,134 · cited 1×
“To predict the effects of lesioning prior to a thalamotomy in the ventral intermediate (Vim) nucleus of the thalamus, surgeons used highfrequency stimulation, which yielded a sustained and immediately reversible effect on tremor (Benabid et al, 1996).”
MethodPerlmutter, J. S., & Mink, J. W. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112824 · Cited by 1,073 · cited 1×
“Dopamine is a well-known therapeutic for treating movement disorders, such as PD, that are characterized by reduced dopamine production (Perlmutter & Mink, 2006).”
Cited by
Bach, P., Luderer, M., Müller, U. J., Jakobs, M., Baldermann, J. C., Voges, J., Kiening, K., Lux, A., Visser-Vandewalle, V., the DeBraSTRA study group, et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02337-1 · Cited by 65
Self-citation
Metadata
- Authors
- Jakobs, M., Fomenko, A., Lozano, A. M., & Kiening, K. L.
- Venue
- EMBO Molecular Medicine
- Published
- 2019-03-12
- Volume
- 11
- Issue
- 4
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2921116799
- Cited by
- 227
- References
- 175
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.